Non-infectious Uveitis Affecting the Posterior Segment of the Eye

Ophthalmology
1
Pipeline Programs
1
Companies
1
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
1
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

ANI Pharmaceuticals
1 program
1
fluocinolone acetonide 190 microgramsPhase 41 trial
Active Trials
NCT06539481RecruitingEst. Oct 2028

Trial Timeline

Clinical trial activity over time

2024
2025
2026
2027
2028
ANI Pharmaceuticalsfluocinolone acetonide 190 micrograms

Clinical Trials (1)

NCT06539481ANI Pharmaceuticalsfluocinolone acetonide 190 micrograms

Open Label Trial Studying the Safety and Effectiveness of ILUVIEN® (190μg) in Children and Adolescents, Who Have Recurrent Non-infectious Uveitis Affecting the Posterior Segment of the Eye.

Start: Aug 2024Est. completion: Oct 2028
Phase 4Recruiting

Related Jobs in Ophthalmology

Lead Data Manager

Genomics
Remote
5h ago

Cleanroom and Laboratory Technician

SAB BIO
6h ago

Product Specialist

Johnson & Johnson
Hangzhou, Zhejiang, China
22h ago

BM 喀什 PSR HY

Johnson & Johnson
Urumqi, Xinjiang, China
22h ago

Site Delivery Leader MLL

Johnson & Johnson
Gent, East Flanders, Belgium
22h ago

Clinical Operations Manager

Johnson & Johnson
Irvine, California, United States of America
22h ago
$117K - $201K/yr

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 actively recruiting trials
1 companies competing in this space

Related Indications

Myopia(127)Cataract(116)Open-Angle Glaucoma(102)Glaucoma(92)Dry Eye(74)Age-Related Macular Degeneration(73)Dry Eye Disease(43)Neovascular Age-related Macular Degeneration(40)Macular Degeneration(37)Diabetic Retinopathy(25)